Differential Human Renal Tubular Responses to Dopamine Type 1 Receptor Stimulation Are Determined by Blood Pressure Status

Hypertension

Volumn 29, Issue 1, 1997, Pages 115-122

  O'Connell Damian P , Ragsdale Virginia N ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOHIPPURIC ACID; DOPAMINE 1 RECEPTOR STIMULATING AGENT; FENOLDOPAM; INULIN; LITHIUM CARBONATE;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RESPONSE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; MALE; NATRIURESIS; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADULT; BLOOD PRESSURE; CROSS-OVER STUDIES; DOPAMINE AGONISTS; DOUBLE-BLIND METHOD; FEMALE; FENOLDOPAM; HEART RATE; HUMANS; HYPERTENSION; INFUSIONS, INTRAVENOUS; INULIN; KIDNEY TUBULES; LITHIUM; MALE; MIDDLE AGED; NATRIURESIS; RECEPTORS, DOPAMINE D1; RENAL PLASMA FLOW; SODIUM; SODIUM, DIETARY;

EID: 0031041887     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.hyp.29.1.115     Document Type: Article

References (36)

1. Goldblatt H, Lynch J, Hanzal RF. Studies on experimental hypertension, I: the production of persistent elevation of systolic blood pressure by means of renal ischemia. J Exp Med. 1934;59:347-350.
2. Guyton AC, Hall JE, Jackson TE. The basic kidney blood volume-pressure regulatory system: the pressure diuresis and natriuresis phenomena. In: Guyton AC, ed. Arterial Pressure and Hypertension. Philadelphia, Pa: WB Saunders Co; 1980:87-99.
3. Schoback DM, Williams GH, Moore TJ, Dluhy RG, Podolsky S, Hollenberg NK. Defect in sodium-modulated tissue responsiveness to angiotensin II in essential hypertension. J Clin Invest. 1983;72:2115-2124.
4. Sullivan JM. Salt sensitivity: definition, conception, methodology, and long-term issues. Hypertension. 1991;17(suppl I):I-61-I-68.
5. Felder RA, Carey RM. Dopamine in cardiovascular function. In: Buckley JP, Ferrario C, eds. Brain Peptides and Catecholamines in Cardiovascular Regulation in Normal and Disease States. New York, NY: Raven Press Publishers; 1987:79-91.
6. Felder RA, Carey RM. Dopamine in cardiovascular function. In: Buckley JP, Ferrario C, eds. Brain Peptides and Catecholamines in Cardiovascular Regulation in Normal and Disease States. New York, NY: Raven Press Publishers; 1987:79-91.
7. Jose PA, Raymond JR, Bates MD, Aperia A, Felder RA, Carey RM. The renal dopamine receptors. J Am Soc Nephrol. 1992;2:1265-1278.
8. Siragy HM, Felder RA, Howell NL, Chevalier RL, Peach MJ, Carey RM. Evidence that intrarenal dopamine acts as a paracrine substance at the renal tubule. Am J Physiol. 1989;257:F469-F477.
9. Felder CC, Campbell T, Albrecht F, Jose PA. Dopamine inhibits Na-H exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol. 1990;259:F297-F303.
10. Aperia A, Bertorello A, Seri I. Dopamine causes inhibition of Na-K-ATPase activity in rat proximal convoluted tubule segments. Am J Physiol. 1987;252:F39-F45.
11. Wyss JM, Liumsiricharoen M, Sripairojthikoon W, Brown D, Gist R, Oparil S. Exacerbation of hypertension by high chloride, moderate sodium diet in the salt-sensitive spontaneously hypertensive rat. Hypertension. 1987;9(suppl III):III-171-III-175.
12. + -ATPase activity is lacking in Dahl salt-sensitive rats. Hypertension. 1993;21:767-771.
13. Kinoshita S, Sidhu A, Felder RA. Defective dopamine-1 receptor adenylate cyclase coupling in the proximal convoluted tubule from the spontaneously hypertensive rat. J Clin Invest. 1989;84:1849-1856.
14. Heyrovsky A. A new method for determination of inulin in plasma and urine. Clin Chim Acta. 1956;1:470-474.
15. Brun C. A rapid method for the determination of para-aminohippuric acid in kidney function tests. J Lab Clin Med. 1951;37:955-958.
16. Sealey JE, Laragh JH. The renin-angiotensin-aldosterone system for normal regulation of blood pressure and sodium and potassium balance. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis and Management. New York, NY: Raven Press; 1995:1763-1797.
17. Brooker G, Terasaki W, Price M. Gamma flow: a complete automated radioimmunoassay system. Science. 1976;194:270-276.
18. Thomsen K, Schou M. Lithium clearance: a new research area. News Physiol Sci. 1986;1:126-128.
19. Stein RM, Abramson RG, Bercovitch DD, Levitt MF. Effects of unilateral renal arterial constriction on tubular reabsorption of sodium and water during an osmotic diuresis. J Clin Invest. 1965;44:1720-1729.
20. Stein RM, Abramson RG, Kahn T, Levitt MF. Effects of hypotonic saline loading in the hydrated dog: evidence for a saline-induced limit on distal tubular sodium transport. J Clin Invest. 1967;46:1205-1214.
21. Hayslett JP, Kashgarian M. A micropuncture study of the renal handling of lithium. Pflugers Arch. 1979;380:159-163.
22. Thomsen K, Holstein-Rathlou NH, Leyssac PP. Comparison of three measures of proximal tubular reabsorption: lithium clearance, occlusion time, and micropuncture. Am J Physiol. 1981;241:F348-F355.
23. Shirley DG, Walter SJ, Thomsen K. A comparison of micropuncture and lithium clearance methods in the assessment of renal tubular function in rats with diabetes insipidus. Pflugers Arch. 1983;399:266-270.
24. Leyssac PP, Holstein-Rathlou NH. Comment on the lithium clearance method for estimating renal tubular function. News Physiol Sci. 1988;3:77-78.
25. Strazzullo P, Iacoviello L, Iacone R, Giorgione N. Use of fractional lithium clearance in clinical and epidemiological investigation: a methodological assessment. Clin Sci. 1988;74:651-657.
26. Meister B, Fryckstedt J, Schalling M, Cortes R, Hokfelt T, Aperia A, Hemmings HC, Nairn AC, Ehrlich M, Greengard P. Dopamine-regulated and cAMP-regulated phosphoprotein (DARPP-2) and DA1 agonist-sensitive Na/K ATPase in renal tubule cells. Proc Natl Acad Sci U S A. 1989;86:8068-8072.
27. 1 dopamine receptors in renal cortical collecting duct. Am J Physiol. 1991;261:F890-F895.
28. Gill JR Jr, Gullner G, Lake CR, Lakatua DJ, Lan G. Plasma and urinary catecholamines in salt-sensitive idiopathic hypertension. Hypertension. 1988;11:312-319.
29. Gill JR Jr, Grossman E, Goldstein DS. High urinary dopa and low urinary dopamine-to-dopa ratio in salt-sensitive hypertension. Hypertension. 1991;18:614-621.
30. Lee MR. Dopamine, the kidney and essential hypertension. Clin Exp Hypertens A. 1989;11(suppl 1):149-158.
31. Jeffrey RF, McDonald TM, Brown J, Rae WH, Lee MH. The effect of lithium on the renal response to the dopamine prodrug gludopa in normal man. Br J Clin Pharmacol. 1988;25:725-732.
32. 1 -dopamine receptor stimulation by fenoldopam in normal man. Br J Clin Pharmacol. 1990;29:413-415.
33. Schoors DF, Dupont AG. Lithium does not reduce the natriuretic response to dopamine in man. Br J Clin Pharmacol. 1990;29:581-582.
34. Olsen NV, Fogh-Andersen N, Strandgaard S, Leyssac PP. Endogenous versus exogenous lithium clearance for evaluation of dopamine-induced changes in renal tubular function. Clin Sci. 1996;90:511-515.
35. Ohbu K, Felder RA. Nephron specificity of dopamine receptor-adenylyl cyclase defect in spontaneous hypertension. Am J Physiol. 1993;264:F274-F279.
36. Felder RA, Kinoshita S, Sidhu A, Ohbu K, Kaskel FJ. A renal dopamine-1 receptor defect in two genetic models of hypertension. Am J Hypertens. 1990;3:96S-99S.